Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism

Laboratory Investigation

Volumn 84, Issue 4, 2004, Pages 502-512

  Ancelin, Magali ^a   Chollet Martin, Sylvie ^b   Hervé, Marie Astrid ^a   Legrand, Chantal ^a   El Benna, Jamel ^b   Perrot Applanat, Martine ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Chemotaxis; Endometrium; Isoforms; PMN; VEGF

Indexed keywords

BETA1 INTEGRIN; BETA2 INTEGRIN; CD31 ANTIGEN; CELL ADHESION MOLECULE; ISOPROTEIN; L SELECTIN; PROTEIN VEGF165; PROTEIN VEGF189; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 1; CD11B ANTIGEN; FIBRONECTIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DECIDUA; DEGRANULATION; DOWN REGULATION; ENDOMETRIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CELL ADHESION; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENDOMETRIUM; FEMALE; IMMUNOLOGY; MENSTRUATION; NEUTROPHIL; PHYSIOLOGY; VASCULARIZATION;

ANTIGENS, CD11B; ANTIGENS, CD29; CELL ADHESION; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; ENDOMETRIUM; FEMALE; FIBRONECTINS; HUMANS; MENSTRUATION; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 2342475284     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700053     Document Type: Article

References (65)

1. Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
2. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
3. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
4. Sunderkotter C, Steinbrink K, Goebeler M, et al. Macrophages and angiogenesis. J Leukoc Biol 1994;55:410-422.
5. Freeman MR, Schneck FX, Gagnon ML, et al. Peripheral blood T-lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 1995;55:4140-4145.
6. Taichman NS, Young S, Cruchley AT, et al. Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol 1997;62:397-400.
7. Gaudry M, Bregerie O, Andrieu V, et al. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997;90:4153-4161.
8. Webb NJ, Myers CR, Watson CJ, et al. Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 1998;10:254-257.
9. Waltenberger J, Claesson-Welsh L, Siegbahn A, et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994;269:26988-26995.
10. Gitay-Goren H, Soker S, Vlodavsky I, et al. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 1992;267:6093-6098.
11. Park J, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993;4:1317-1326.
12. Houck KA, Leung DW, Rowland AM, et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992;267:26031-26037.
13. Plouët J, Moro F, Bertagnolli S, et al. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J Biol Chem 1997;272:13390-13396.
14. Cheng SY, Nagane M, Huang HJS, et al. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc Natl Acad Sci USA 1997;94:12081-12087.
15. Grunstein J, Masbad JJ, Hickey R, et al. Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol Cell Biol 2000;20:7282-7291.
16. Perrot-Applanat M. Hormonal regulation of vascular cell function. In: Bikfalvi A (ed). Encyclopedic Reference of Vascular Biology and Pathology. Springer Verlag: Berlin, 2000, PP. 157-162.
17. Torry DS, Holt VJ, Keenan JA, et al. Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril 1996;66:72-80.
18. Shifren JL, Tseng JF, Zaloudek CJ, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-3118.
19. Bausero P, Cavaillé F, Meduri G, et al. Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. Angiogenesis 1998;2:167-182.
20. Zhang L, Rees MC, Bicknell R. The isolation and long-term culture of normal human endometrial epithelium and stroma. Expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges. J Cell Sci 1995;108:323-331.
21. Hyder M, Stancel GM, Chiappetta C, et al. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res 1996;56:3954-3960.
22. Ancelin M, Buteau-Lozano H, Meduri G, et al. A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus. Proc Natl Acad Sci USA 2002;99:6023-6028.
23. Poropatich C, Rojas M, Silverberg SG. Polymorphonuclear leukocytes in the endometrium during the normal menstrual cycle. Int J Gynecol Pathol 1987;6:230-234.
24. Critchley HO, Kelly RW, Lea RG, et al. Sex steroid regulation of leukocyte traffic in human decidua. Hum Reprod 1996;11:2257-2262.
25. Gargett CE, Lederman F, Heryanto B, et al. Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium. Role of intravascular neutrophils. Hum Reprod 2001;16:1065-1075.
26. King A, Welling V, Gardner L, et al. Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum Immunol 1989;24:195-205.
27. Barleon B, Sozzani S, Zhou D, et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996;87:3336-3343.
28. Clauss M, Weich H, Breier G, et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996;271:17629-17634.
29. Hayashibara T, Yamada Y, Miyanishi T, et al. Vascular endothelial growth factor and cellular chemotaxis; a possible autocrine pathway in adult T-cell leukemia cell invasion. Clin Cancer Res 2001;7:2719-2726.
30. Lee TH, Avraham H, Lee SH, et al. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem 2002;277:10445-10451.
31. Grenier A, Dehoux M, Boutten A, et al. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 1999;93:1413-1421.
32. Grenier A, Chollet-Martin S, Crestani B, et al. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood 2002;99:2997-3004.
33. Nelson RD, Quie PG, Simmons RL. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 1975;115:1650-1656.
34. Vicioso MA, Garaud JJ, Réglier-Poupet H, et al. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro. Eur Cytokine Netw 1998;9:247-253.
35. Sixt M, Hallmann R, Wendler O, et al. Cell adhesion and migration properties of 2-integrin negative polymorphonuclear granulocytes on defined extracellular matrix molecules. J Biol Chem 2001;276:18878-18887.
36. Harler MB, Wakshull E, Filardo EJ, et al. Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins. J Immunol 1999;162:6792-6799.
37. Loike JD, Cao L, Budhu S, et al. Blockade of α5β1 integrins reverses the inhibitory effect of tenascin on chemotaxis of human monocytes and polymorphonuclear leukocytes through three-dimentional gels of extracellular matrix proteins. J Immunol 2001;166:7534-7542.
38. Brekken RA, Overholser JP, Stastny VA, et al. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Cancer Res 2000;60:5117-5124.
39. Chollet-Martin S, Montravers P, Gibert C, et al. Subpopulation of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome. Role of cytokine production. Am Rev Respir Dis 1992;146:990-996.
40. Borregaard N, Heiple JM, Simons ER, Clark RA. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol 1983;9:52-61.
41. Meduri G, Bausero P, Perrot-Applanat M. Expression of vascular endothelial growth factors in the human endometrium: modulation during the menstrual cycle. Biol Reprod 2000;62:439-447.
42. Clauss M, Gerlach M, Gerlach H, et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990;172:1535-1545.
43. Zhang H, Isseukutz AC. Growth factor regulation of neutrophil-endothelial cell interactions. J Leukoc Biol 2001;70:225-232.
44. Seetharam L, Gotoh N, Maru Y, et al. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 1995;10:135-147.
45. Gille H, Kowalski J, Li B, et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). J Biol Chem 2001;276:3222-3230.
46. Koolwijk P, Peters E, Van der Vecht B, et al. Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro. Angiogenesis 2001;4:53-60.
47. Hattori K, Heissig B, Wu Y, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment. Nature Med 2002;8:841-849.
48. Kubes P, Niu XF, Smith CW, et al. A novel beta 1-dependant adhesion pathway on neutrophiles: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J 1995;9:1103-1111.
49. 1 (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. Blood 2000;95:1804-1809.
50. 1 integrins are critically involved in neutrophil locomotion in extravascular tissue in vivo. J Exp Med 1998;187:2091-2096.
51. 4 integrin. Circ Res 1997;81:196-201.
52. 1 integrin receptors in human neutrophils. J Leukoc Biol 2000;68:553-560.
53. Scapini P, Calzetti F, Cassatella MA. On the detection of neutrophil-derived vascular endothelial growth factor (VEGF). J Immunol Methods 1999;232:121-129.
54. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-1801.
55. Ethuin F, Delarche C, Benslama S, et al. Interleukin-12 increases interleukin 8 production and release by polymorphonuclear neuutrophils. J Leukoc Biol 2001;70:439-443.
56. Dubravec DB, Spriggs DR, Mannick JA, et al. Circulating human peripheral blood granulocytes synthetize and secrete tumor necrosis factor a. Proc Natl Acad Sci USA 1990;87:6758-6761.
57. Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 1981;289:646-650.
58. Detmar M, Brown L, Claffey K, et al. Overexpression of vascular permeability factor and its receptors in psoriasis. J Exp Med 1994;180:1141-1146.
59. Koch AE, Harlow LA, Haines GK, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-4156.
60. Enomoto H, Inoki I, Komiya K, et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 2003;162:171-181.
61. Finn C. Implantation, menstruation and inflammation. Biol Rev Camb Philos Soc 1986;61:313-328.
62. Lathbury LJ, Salamonsen LA. In vitro studies of the potential role of neutrophils in the process of menstruation. Mol Hum Reprod 2000;6:899-906.
63. Mueller MD, Lebovic DI, Garrett E, et al. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril 2000;74:107-112.
64. Freitas S, Meduri G, Le Nestour E, et al. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol Reprod 1999;61:1070-1082.
65. Shaw RW. Assessment of medical treatment of menorrhagia. Br J Obstet Gynaecol 1994;101:15-18.